{"id":8940,"date":"2020-04-14T18:08:34","date_gmt":"2020-04-14T12:38:34","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=8940"},"modified":"2021-07-24T12:57:52","modified_gmt":"2021-07-24T07:27:52","slug":"recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","title":{"rendered":"In the fight against COVID-19 \u2013 Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><strong>Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.&nbsp;<\/strong><\/h2>\n\n\n\n<p>The company plans to explore the anti-inflammatory responses that were witnessed in <a href=\"https:\/\/www.delveinsight.com\/report-store\/rheumatoid-arthritis-ra-market\">rheumatoid arthritis<\/a> patients, and how the drug \u2013 Olumiant \u2013 an oral JAK1\/JAK2 inhibitor \u2013 might help in curing <a href=\"https:\/\/www.delveinsight.com\/blog\/coronavirus\/\">COVID-19<\/a>. The trial would be conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID).<\/p>\n\n\n\n<p>The decision of the company might have been influenced by the anecdotal evidence that showed anti-inflammatory drugs such as Gilead\u2019s Remdesiver and Roche\u2019s Actemra have the potential to treat COVID-19 patients.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Additionally, the company is also advancing the studies of LY3127804 &#8211; an investigational selective monoclonal antibody against Angiopoietin 2 (Ang2)) &#8211; to Phase II testing in <a href=\"https:\/\/www.delveinsight.com\/report-store\/pneumonia-pneumococcal-market\">pneumonia <\/a>patients with COVID-19 at risk of developing ARDS. The company is actively putting efforts in fighting <a href=\"https:\/\/www.delveinsight.com\/blog\/coronavirus-2019-ncov-is-now-covid-19\/\">COVID-19<\/a> by advancing the clinical trials and partnering with pharma companies such as Vancouver-based AbCellera to co-develop antibodies to fight novel coronavirus.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Gilead Sciences announces the promising results of clinical trials for its experimental antiviral drug remdesivir against COVID-19.&nbsp;<\/strong><\/h2>\n\n\n\n<p>&nbsp;The company is running at least five clinical trials for its antiviral drug remdesivir \u2013 out of which two are Phase III trials \u2013 the SIMPLE trials.&nbsp;<\/p>\n\n\n\n<p>More than 1,800 patients have been given the drug on an individual compassionate use basis. Out of which the drug improved the course of the disease in 53 of those patients. Half of the patients were on mechanical ventilation and four were on a heart-lung by-pass machine, and eight were excluded because of erroers and other reasons.&nbsp;<\/p>\n\n\n\n<p>All the patients were given remdesivir for up to 10 days. Over 18 days, 68% showed improvement, with 17 of the 30 patients on ventilators able to be taken off the devices. Almost half of patients were discharged, while 13% died. The study also showed higher mortality in patients receiving ventilation. However, the results from SIMPLE trials are still not out and are expected to be announced within the month.&nbsp;<\/p>\n\n\n\n<p>The drug was originally developed to cure Ebola; however, it was proved to be ineffective.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The US FDA has recommended the use of Rutgers\u2019 Saliva Test under EUA for diagnosing COVID-19.&nbsp;<\/strong><\/h2>\n\n\n\n<p>Rutgers University\u2019s RUCDR Infinite Biologics has developed a diagnostic test that uses saliva and is developed by RUCDR with Spectrum Solutions and Accurate Diagnostic Labs (ADL).<\/p>\n\n\n\n<p>At present, the testing kits require swab from deep in the nasal passages or the back of the throat, which puts healthcare workers at risk of catching an infection. However; saliva testing is a new development and will not require the help of medical care provider.&nbsp;<\/p>\n\n\n\n<p>The company joins several others who have had approval for the use of their diagnostic kits for <a href=\"https:\/\/www.delveinsight.com\/blog\/questions-and-answers-on-coronavirus-covid-19\/\">COVID-19<\/a>, including North Carolina-based Cellex, Mayo Clinic, and Stanford Medicine.&nbsp;<\/p>\n\n\n\n<p>This is the second novel approach to test <a href=\"https:\/\/www.delveinsight.com\/blog\/hydroxychloroquine-and-covid-19\/\">COVID-19<\/a>, after the university launched a genetic testing services that can test thousands of samples daily.<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.&nbsp; The company plans to explore the anti-inflammatory responses that were witnessed in rheumatoid arthritis patients, and how the drug \u2013 Olumiant \u2013 an oral JAK1\/JAK2 inhibitor \u2013 might help in curing COVID-19. The trial would be conducted in [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8950,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[12146,7859,10830,228,1393,349,639,4502,5789,16756,2019,18231],"industry":[17225],"therapeutic_areas":[17227,17231,17243],"class_list":["post-8940","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-ards","tag-coronavirus","tag-covid-19","tag-eli-lilly","tag-gilead-sciences","tag-latest-pharma-news","tag-pharma-news","tag-pneumonia","tag-recent-pharma-news","tag-remdesivir","tag-rheumatoid-arthritis","tag-rutgers","industry-pharmaceutical","therapeutic_areas-immunological-and-autoimmune-disorders","therapeutic_areas-infectious-diseases","therapeutic_areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Lilly\u2019s Olumiant, Gilead\u2019s remdesivir, Rutgers\u2019testing kit against COVID-19<\/title>\n<meta name=\"description\" content=\"Pharma companies like Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit are putting efforts and advancing in the fight against COVID-19\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lilly\u2019s Olumiant, Gilead\u2019s remdesivir, Rutgers\u2019testing kit against COVID-19\" \/>\n<meta property=\"og:description\" content=\"Pharma companies like Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit are putting efforts and advancing in the fight against COVID-19\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-14T12:38:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:27:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Lilly\u2019s Olumiant, Gilead\u2019s remdesivir, Rutgers\u2019testing kit against COVID-19","description":"Pharma companies like Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit are putting efforts and advancing in the fight against COVID-19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","og_locale":"en_US","og_type":"article","og_title":"Lilly\u2019s Olumiant, Gilead\u2019s remdesivir, Rutgers\u2019testing kit against COVID-19","og_description":"Pharma companies like Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit are putting efforts and advancing in the fight against COVID-19","og_url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-04-14T12:38:34+00:00","article_modified_time":"2021-07-24T07:27:52+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers","name":"Lilly\u2019s Olumiant, Gilead\u2019s remdesivir, Rutgers\u2019testing kit against COVID-19","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news.jpg","datePublished":"2020-04-14T12:38:34+00:00","dateModified":"2021-07-24T07:27:52+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Pharma companies like Lilly with Olumiant, Gilead with remdesivir, Rutgers with testing kit are putting efforts and advancing in the fight against COVID-19","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-eli-lilly-gilead-fda-rutgers#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news.jpg","width":772,"height":482,"caption":"covid-news"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/04\/14180640\/covid-news-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">ARDS<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Coronavirus<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">COVID-19<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Eli Lilly<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">gilead sciences<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Latest pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">pneumonia<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">recent pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">remdesivir<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">rheumatoid arthritis<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Rutgers<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">ARDS<\/span>","<span class=\"advgb-post-tax-term\">Coronavirus<\/span>","<span class=\"advgb-post-tax-term\">COVID-19<\/span>","<span class=\"advgb-post-tax-term\">Eli Lilly<\/span>","<span class=\"advgb-post-tax-term\">gilead sciences<\/span>","<span class=\"advgb-post-tax-term\">Latest pharma news<\/span>","<span class=\"advgb-post-tax-term\">pharma news<\/span>","<span class=\"advgb-post-tax-term\">pneumonia<\/span>","<span class=\"advgb-post-tax-term\">recent pharma news<\/span>","<span class=\"advgb-post-tax-term\">remdesivir<\/span>","<span class=\"advgb-post-tax-term\">rheumatoid arthritis<\/span>","<span class=\"advgb-post-tax-term\">Rutgers<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Apr 14, 2020","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Apr 14, 2020 6:08 pm","modified":"Updated on Jul 24, 2021 12:57 pm"},"featured_img_caption":"covid-news","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/8940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=8940"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/8940\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/8950"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=8940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=8940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=8940"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=8940"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=8940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}